Hamilton Thorne to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
May 01, 2018 11:30 am UTC| Business
BEVERLY, Mass. and TORONTO, May 01, 2018 -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and...
Plandai Biotechnology Discusses How Green Tea Combats Type 2 Diabetes
May 01, 2018 11:30 am UTC| Business
Natural Solution Provides Positive Mitigation Against Type 2 Diabetes LONDON, UNITED KINGDOM, May 01, 2018 -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical...
Adherium Announces Program with Vitalus Health on World Asthma Day
May 01, 2018 11:30 am UTC| Business
SAN MATEO, Calif., May 01, 2018 -- In conjunction with World Asthma Day, Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, announced today it has agreed to launch a...
Intellia Therapeutics Announces First Quarter 2018 Financial Results
May 01, 2018 11:30 am UTC| Business
New CEO puts in vivo and ex vivo genome editing on parallel tracks towards the clinic Company anticipates submitting its in vivo Investigational New Drug application by the end of 2019 for systemic lipid nanoparticle...
May 01, 2018 11:30 am UTC| Business
REDWOOD CITY, Calif., May 01, 2018 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that...
May 01, 2018 11:30 am UTC| Business
VANCOUVER, B.C., May 01, 2018 -- VR Resources Ltd. (TSX.V:VRR) (FSE:5VR) (OTCBB:VRRCF), the "Company", or “VR”, is pleased to announce the acquisition of the Kraut property, to expand its epithermal gold exploration...
KemPharm, Inc. to Report First Quarter 2018 Results
May 01, 2018 11:30 am UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for May 10, 2018, 4:30 p.m. ET CORALVILLE, Iowa, May 01, 2018 -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the...